BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.2.3.1//EN BEGIN:VEVENT UID:2@biocityturku.fi DTSTART;TZID=Europe/Helsinki:20230613T140000 DTEND;TZID=Europe/Helsinki:20230613T150000 DTSTAMP:20230812T173848Z URL:https://biocityturku.fi/events/immunology-seminar-fiona-powrie/ SUMMARY:Immunology Seminar: Fiona Powrie DESCRIPTION:June 13th at 14:00–15:00\nVirtual event\n\nFiona Powrie\, Uni versity of Oxford\, UK\nTranslating immunology into new therapies for Infl ammatory Bowel Disease\n\nHost: Riitta Lahesmaa (rilahes@utu.fi )\n\nRegis tration latest June 12th at https://link.webropolsurveys.com/S/D08980F9859 1B2B7\n\nImmunology seminar series is jointly organised by the Finnish Soc iety for Immunology\, InFLAMES Flagship and Turku Bioscience. For further information contact Anne Lahdenperä (ankahy@utu.fi) or Riitta Lahesmaa (r ilahes@utu.fi)\, University of Turku.\n\n \;\n\nProfessor Dame Fiona P owrie is Director of the Kennedy Institute of Rheumatology\, University of Oxford\, a Fellow of the Royal Society and the Academy of Medical Science s and a Governor of the Wellcome Trust. She gained a PhD in immunology at the University of Oxford and then moved to the DNAX Research Institute in Palo Alto\, before returning to Oxford in 1996 as a Wellcome Trust Senior Research Fellow. Prior to her appointment to the Kennedy Institute\, Fiona Powrie was the Sidney Truelove Professor of Gastroenterology and Head of the Translational Gastroenterology Unit\, Oxford (2009- 2014). Her researc h examines the relationship between the intestinal microbiome and the host immune system and how this mutualistic relationship breaks down in inflam matory bowel disease\, arthritis and cancer. Fiona Powrie has received num erous prestigious prizes and awards\, including the Louis Jeantet Prize fo r Medicine in 2012. She was elected an international member of the Nationa l Academy of Sciences in 2020 and was appointed Deputy Chair of the Wellco me Board of Governors and Dame Commander of the Most Excellent Order of th e British Empire (DBE)\, for services to Medical Science\, in 2022.\n\n&nb sp\;\n\nSelected publications\n\nFriedrich M\, Pohin M\, Jackson MA\, Kors unsky I\, ...\, Thomas L\, Collantes E\, Uhlig HH\, Sansom SN\, Easton A\, Raychaudhuri S\, Travis SP\, Powrie FM. IL-1-driven stromal-neutrophil in teractions define a subset of patients with inflammatory bowel disease tha t does not respond to therapies. Nat Med. 2021 Nov\;27(11):1970-1981\n\nAs chenbrenner D\, Quaranta M\, Banerjee S\, ...\, Powrie F\, Sansom SN\, Uhl ig HH. Deconvolution of monocyte responses in inflammatory bowel disease r eveals an IL-1 cytokine network that regulates IL-23 in genetic and acquir ed IL-10 resistance. Gut. 2021 Jun\;70(6):1023-1036\n\nRyzhakov G\, West N R\, Franchini F\, Clare S\, Ilott NE\, Sansom\, SN\, ...\, Powrie F. 2018 Alpha kinase 1 controls intestinal inflammation by suppressing the IL-12/T h1 axis. Nat Commun 9(1):3797\n\nHegazy AN\, West NR\, Stubbington MJT\, W endt E\, ...\, Teichmann SA\, Keshav S\, Powrie F. 2017. Circulating and T issue-Resident CD4(+) T Cells With Reactivity to Intestinal Microbiota Are Abundant in Healthy Individuals and Function Is Altered During Inflammati on. Gastroenterology 153: 1320-37 e16 END:VEVENT BEGIN:VTIMEZONE TZID:Europe/Helsinki X-LIC-LOCATION:Europe/Helsinki BEGIN:DAYLIGHT DTSTART:20230326T040000 TZOFFSETFROM:+0200 TZOFFSETTO:+0300 TZNAME:EEST END:DAYLIGHT END:VTIMEZONE END:VCALENDAR